Gadolinium-enhanced cardiovascular magnetic resonance: administered dose in relationship to united states food and drug administration (FDA) guidelines

被引：0
|
作者：
Marcelo S Nacif
Andrew E Arai
Joao AC Lima
David A Bluemke
机构：
[1] Radiology and Imaging Sciences - National Institutes of Health Clinical Center,Division of Cardiology
[2] Johns Hopkins University School of Medicine,Radiology Department
[3] Universidade Federal Fluminense,Cardiovascular and Pulmonary Branch, National Heart
[4] Lung,Molecular Biomedical Imaging Laboratory
[5] and Blood Institute - National Institutes,undefined
[6] National Institute of Biomedical Imaging and Bioengineering,undefined
来源：
Journal of Cardiovascular Magnetic Resonance | / 14卷
关键词：
Contrast media; Gadolinium; Heart; Magnetic resonance imaging;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] The ABCs of the FDA: A Primer on the Role of the United States Food and Drug Administration in Medical Device Approvals and IR Research
    Adamovich, Ashley
    Park, Susie
    Siskin, Gary P.
    Englander, Meridith J.
    Mandato, Kenneth D.
    Herr, Allen
    Keating, Lawrence J.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2015, 26 (09) : 1324 - 1330
  • [32] Delayed Gadolinium-Enhanced Magnetic Resonance Imaging of Medial Tibiofemoral Cartilage and Its Relationship With Meniscal Pathology A Longitudinal Study Using 3.0T Magnetic Resonance Imaging
    Crema, Michel D.
    Hunter, David J.
    Burstein, Deborah
    Roemer, Frank W.
    Li, Ling
    Krishnan, Nitya
    Marra, Monica D.
    Le-Graverand, Marie-Pierre Hellio
    Guermazi, Ali
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (06) : 1517 - 1524
  • [33] Late gadolinium-enhanced cardiovascular magnetic resonance evaluation of infarct size and microvascular obstruction in optimally treated patients after acute myocardial infarction
    Nijveldt, Robin
    Beek, Aernout M.
    Hofman, Mark B. M.
    Umans, Victor A. W. M.
    Algra, Paul R.
    Spreeuwenberg, Marieke D.
    Visser, Cees A.
    van Rossum, Albert C.
    JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2007, 9 (05) : 765 - 770
  • [34] 2049 Improved detection of myocardial fibrosis using high-resolution, late gadolinium-enhanced cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy
    Caitlin J Harrigan
    Dana C Peters
    Martin S Maron
    Barry J Maron
    C Michael Gibson
    Warren J Manning
    Evan Appelbaum
    Journal of Cardiovascular Magnetic Resonance, 10 (Suppl 1)
  • [35] THE EFFECTS OF HIGH-DOSE METHYLPREDNISOLONE ON GADOLINIUM-ENHANCED MAGNETIC-RESONANCE-IMAGING AND CEREBROSPINAL-FLUID MEASUREMENTS IN MULTIPLE-SCLEROSIS
    FREQUIN, STFM
    BARKHOF, F
    LAMERS, KJB
    HOMMES, OR
    JOURNAL OF NEUROIMMUNOLOGY, 1992, 40 (2-3) : 265 - 272
  • [36] Magnetic resonance urography for the assessment of potential renal donors: comparison of the RARE technique with a low-dose gadolinium-enhanced magnetic resonance urography technique in the absence of pharmacological and mechanical intervention
    Klaus D. Hagspiel
    Sabah Butty
    Kiran R. Nandalur
    Eric A. Bissonette
    Ming-Chen Paul Shih
    Daniel A. Leung
    J. Fritz Angle
    David J. Spinosa
    Alan H. Matsumoto
    Hossam Ahmed
    Hilary Sanfey
    Ross B. Isaacs
    Robert G. Sawyer
    Timothy L. Pruett
    European Radiology, 2005, 15 : 2230 - 2237
  • [37] Magnetic resonance urography for the assessment of potential renal donors: comparison of the RARE technique with a low-dose gadolinium-enhanced magnetic resonance urography technique in the absence of pharmacological and mechanical intervention
    Hagspiel, K
    Butty, S
    Nandalur, KR
    Bissonette, EA
    Shih, MCP
    Leung, DA
    Angle, JF
    Spinosa, DJ
    Matsumoto, AH
    Ahmed, H
    Sanfey, H
    Isaacs, RB
    Sawyer, RG
    Pruett, TL
    EUROPEAN RADIOLOGY, 2005, 15 (11) : 2230 - 2237
  • [38] WHAT ARE THE FOOD-AND-DRUG-ADMINISTRATION (FDA) REQUIREMENTS FOR IDENTIFYING DRUG-INTERACTIONS WHEN A DRUG IS BEING DEVELOPED FOR MARKETING IN THE UNITED-STATES
    SHADER, RI
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1994, 14 (03) : 220 - 220
  • [39] Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance
    Soriano, CJ
    Ridocci, F
    Estornell, J
    Jimenez, J
    Martinez, V
    De Velasco, JA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (05) : 743 - 748
  • [40] Moving-table reduced-dose gadolinium-enhanced three-dimensional magnetic resonance angiography: Velocity-dependent method with three-phase gadolinium infusion
    Kita, M
    Mitani, Y
    Tanihata, H
    Kita, K
    Sato, M
    Takizawa, O
    Laub, G
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2001, 14 (03) : 319 - 328
12345